Tumor cells typically contain a genome that is highly divergent from the genome of normal, non-transformed cells. This genetic divergence is caused by a number of distinct changes that the tumor cell acquires during its transformation from a normal cell into a tumorigenic counterpart. Changes to the genome include mutations, deletions, insertions, and also gross chromosomal aberrations, such as chromosome translocations and whole chromosome gains or losses. This genetic disorder of the tumor cell has complicated the identification of crucial driver mutations that cause cancer. Moreover, the large genetic divergence between different tumors causes them to behave very differently, and makes it difficult to predict response to therapy. In addition, tumor cells are genetically unstable and frequently acquire new mutations and/or gross chromosomal aberrations as they divide. This is beneficial for the overall capacity of a tumor to adapt to changes in its environment, but newly acquired genetic alterations can also compromise the genetic dominance of the tumor cell and thus affect tumor cell viability. Here, we review the mechanisms that can cause gross chromosomal aberrations, and discuss how these affect tumor cell viability.
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( Figure 1 ). In hematological malignancies, several translocations have been identified that contribute to specific gene fusions, which are thought to be drivers in the process of tumorigenesis. 2 The first identified translocation in human cancer was the Philadelphia chromosome, 3 which results in the formation of a fusion between the BCR and Abl genes, and is causative in the development of chronic myeloid leukemia. 4 Translocations found in cancer can be balanced, creating two reciprocal chromosomal fusions that are homogeneously present in all tumor cells. 5 However, more often, cancer cells within a tumor display mosaic structural changes, indicating that chromosomes continue to rearrange at a high rate in the established tumor. [6] [7] [8] [9] [10] [11] Generally, these chromosome structure instabilities are thought to promote tumorigenesis by providing continuous genetic diversification within the tumor that facilitates adaptation to environmental changes, for example through loss of certain tumor suppressors or gain of specific oncogenes. 7, 12 Moreover, this continued genetic diversification could help the tumor in acquiring drug resistance, cope with increased hypoxia, or escape challenges by the immune system. In line with this, an increased occurrence of structural chromosomal aberrations correlates with increased tumor grade. 1, 13, 14 Structural chromosomal instabilities arise through mis-or unrepaired DNA double-stranded breaks (DSBs). Homologous recombination and non-homologous end joining are thought to be the two main repair pathways contributing to the formation of structural aberrations. [15] [16] [17] Especially the error-prone nonhomologous end joining pathway, which can ligate any two broken DNA ends together, is held responsible for the formation of structural aberrations. 15 Indeed, individuals with genetic defects that affect repair of DSBs, such as patients with Nijmegen Breakage Syndrome, Bloom's syndrome, ataxia telangiectasia or mutations in BRCA1 and 2, display an increased susceptibility to form structural chromosomal changes. 18 Cells from these patients accumulate translocations due to mutations in DNA repair proteins, such as NBS1, BLM helicase, ATM kinase or the BRCA1 and BRCA2 proteins. Moreover, it was shown long ago that several DSB-inducing agents, such as ionizing irradiation, UV-light and chemical mutagens, can also result in the formation of chromosomal aberrations. 19 The structural instability of cancer cells is not merely caused by inherited genetic defects or damage induced by exogenous agents. Cancer cells can also acquire new translocations through the breakage-fusion-bridge (BFB) cycle, a process first described in maize meiosis. 20, 21 In the BFB cycle, chromosomes that are broken by DSBs first fuse with other broken chromosomal parts, for example, through fusion at dysfunctional telomeres. 22 These telomere fusion events result in dicentric (two centromeres) chromosomes, often found in tumors. 22, 23 The presence of two centromeres on these aberrantly shaped chromosomes can result in improper microtubule (MT) attachments in mitosis, such that the two centromeres on a single chromatid become attached to opposite spindle poles. These attachments can induce chromatin bridging in telophase, resulting in breakage of the fused chromosome during cytokinesis, starting another BFB cycle. 20, 24 Such repetitive BFB events increase the number of aberrant chromosomes in the offspring. 20, 21 BFB has indeed been correlated with an increase in intratumor heterogeneity and might therefore be an important factor in structural instability. 25 
NUMERICAL CHROMOSOMAL INSTABILITY
Another striking hallmark of cancer cells is the presence of an abnormal chromosome number aneuploidy, a state in which cells do not contain an exact multiple of the haploid DNA content. On average, 25 percent of the genome of a cancer cell is affected by numerical changes of either whole chromosomes or complete chromosomal arms. 6 The aneuploid karyotype can be stably propagated in a population of (tumor) cells, 6, 28, 29 but more often chromosome numbers continuously change between cancer cells and their offspring. 30 This continuous change in chromosome number is termed whole chromosomal instability (CIN) 30.31 and is correlated with tumor grade, metastasis and poor prognosis. [32] [33] [34] [35] [36] [37] [38] Moreover, CIN has been associated with resistance to chemotherapeutics, such as the widely used MT-stabilizing agent Paclitaxel. [39] [40] [41] Various hypotheses have been postulated on how CIN and aneuploidy could contribute to tumorigenesis. [42] [43] [44] [45] [46] The general idea is that whole chromosome gains and losses during cell division can, as suggested above for structural changes, provide a mode for cancer cells to adapt to their environment and continuously divide. 47, 48 CAUSES OF NUMERICAL CIN Since the initial discovery of CIN in a variety of colon cancer cell lines in 1997, 30 many researchers have investigated the underlying cause of this striking phenotype, found to be present in many other tumor types as well. Several mechanisms have been proposed and tested using a variety of cancer cell lines and mouse models. It seems highly unlikely that one single mechanism can be held responsible for the CIN observed in the different types of tumors. Below we outline the different cellular causes that have been postulated and the genetic defects that could underlie these phenotypes.
Causes of numerical CIN: Mitotic checkpoint defects
The mitotic checkpoint has evolved to safeguard genetic stability, a function it performs by monitoring the attachment status of chromosomes to the mitotic spindle. During mitosis, sister chromatid pairs need to bi-orient on the mitotic spindle, meaning that sister chromatids within a pair are attached to opposite spindle poles. Improper attachment of as much as a single sister chromatid is sufficient to sustain the mitotic checkpoint and prevent the onset of anaphase. Biorientation is achieved through binding of the MT attachment site of each sister chromatid, called kinetochore, to MTs coming from one spindle pole. Once all kinetochores in a cell are properly attached to the spindle, the mitotic checkpoint is satisfied and anaphase onset is no longer inhibited. 49 Defects in mitotic checkpoint signaling directly lead to chromosome missegregations by allowing mitotic exit in the presence of unattached kinetochores (Figure 2) . Indeed, the hypothesis that has been investigated the most, postulates that mitotic checkpoint defects could underlie CIN. 50 Complete mitotic checkpoint loss is lethal to all dividing cell types studied thus far and causes embryonic lethality in mouse, [51] [52] [53] [54] [55] [56] [57] [58] likely because it results in continuous chromosome missegregation. Thus, subsequent cell divisions of a viable aneuploid karyotype results in improper propagation of the genetic material, resulting in high rates of cell death in the respective daughter cells. In contrast, partial checkpoint dysfunction results in a low frequency of chromosome segregation errors, a low rate of cell death and the potential to generate a new viable karyotype that is relatively stable. Partial mitotic checkpoint activity could be responsible for CIN in tumor cells by allowing mitotic exit in the presence of one or more unattached kinetochores (Figure 2) . 51, [58] [59] [60] However, CIN cancer cell lines that were initially thought to have a severely impaired mitotic checkpoint due to mutations in the mitotic checkpoint kinase Bub1, 61 were subsequently shown to have a very sturdy mitotic checkpoint. 62 Nonetheless, altered expression levels and mutations in mitotic checkpoint genes have been identified in human cancer that compromise checkpoint function. 43, [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] In one specific syndrome, mosaic-variegated aneuploidy, which is linked to cancer predisposition at a very young age, mono-and biallelic mutations in the BUB1B gene have been identified. 63 BUB1B encodes for the mitotic checkpoint protein BubR1 and these mutations can lead to the complete absence of BubR1 mRNA or single amino-acid substitutions in the BubR1 protein product. 77 In all cases, these mutations lead to lower BubR1 protein levels and decreased mitotic checkpoint activity, 64, 77, 78 linking the cancer predisposition of mosaicvariegated aneuploidy patients to defects in the mitotic checkpoint.
The occurrence of mutations in mitotic checkpoint genes in human cancers remains extremely rare. [79] [80] [81] [82] Surprisingly, many CIN tumors actually display enhanced levels of mitotic checkpoint proteins. 33, [83] [84] [85] [86] [87] [88] [89] One explanation for this increase in expression of mitotic checkpoint genes lies in the dysfunction of the Rb pathway, resulting in overexpression of the mitotic checkpoint protein MAD2. 90 Indeed, deregulation of the Rb pathway can result in CIN in several organisms. 91, 92 Notably, CIN induced in Rb-negative cell lines was directly dependent on increased MAD2 levels. 90 In line with this, MAD2 overexpression in mice results in aneuploidy and spontaneous tumor formation 93 (See Table 1 ) and CIN in Rb-negative tumors depends on increased MAD2 levels. 94 In summary, decreased expression levels of checkpoint proteins as well as mutations in mitotic checkpoint genes have been observed in tumor tissues, but these are relatively rare. Instead, mere overexpression of mitotic checkpoint proteins, in particular MAD2, seems to be the more prevalent cause in the induction of CIN in various tumor types.
Causes of numerical CIN: cohesion loss Duplicated sister chromatids are held together until anaphase by the cohesin complex. Maintenance of cohesion between the two sister centromeres is essential for chromosome biorientation and hence for proper chromosome segregation. [95] [96] [97] Loss of cohesion before anaphase results in premature sister chromatid separation, which eventually results in chromosome segregation errors and aneuploidy ( Figure 2 ). Various genes encoding proteins involved in cohesion establishment or maintenance have been found to be mutated in aneuploid tumors. 96, 98 In addition, a recent report observed frequent deletion of part of the X chromosome in genetically unstable tumor samples. 99 This locus encodes for SA2, which is a subunit of the cohesin complex. Interestingly, targeted inactivation of this locus, termed STAG2, resulted in CIN in otherwise chromosome-stable near-diploid cells. Moreover, reconstitution of STAG2 in CIN tumor cells harboring a deletion of the endogenous locus, reverted the CIN phenotype and enhanced chromosomal stability in these lines. 99 Defective sister chromatid cohesion as a result of somatic mutations may represent a major cause of CIN in human cancers. In line with this, overexpression of Separase, the protease that cleaves cohesin upon mitotic exit, has been observed in breast cancer samples and transient overexpression of Separase can also produce aneuploidy in human cells. 100 Besides its role in sister chromatid cohesion, cohesin has also been implicated in DNA replication, repair of DNA damage and protection of telomeres. 101 Therefore, various other mechanisms might underlie the aneuploidy observed in cells that carry mutations in one of the cohesin subunits 102 and further research is needed to investigate the contribution of cohesion defects in the establishment of CIN.
Causes of numerical CIN: Merotelic attachments Although CIN cell lines do not necessarily possess a weakened mitotic checkpoint, many CIN cell lines do have an increased occurrence of lagging chromosomes due to unresolved merotelic attachments to the mitotic spindle 103, 104 ( Figure 2 ). Merotelic attachments link a single kinetochore to two spindle poles, instead of one. If this merotelic attachment persists, the respective sister chromatid will end up in between the two packs of DNA during anaphase, producing a lagging chromosome 105, 106 ( Figure 2 ). Most merotelic attachments are resolved by the Aurora B-dependent error-correction machinery before anaphase. 12, [107] [108] [109] However, merotelic attachments are not actively being sensed by the mitotic checkpoint and therefore do not delay mitotic exit to allow for correction. Such merotelic attachments can therefore persist into anaphase and cause chromosome missegregations and aneuploidy. 103, 106 Although not all lagging chromosomes necessarily lead to aneuploidy in the respective daughter cells, 12 merotelic attachments are very prominent in CIN cells and therefore thought to be a major cause of aneuploidy.
As indicated in Figure 2 , loss of cohesion between two sister chromatids could increase the occurrence of merotelic attachments. In the absence of cohesion, kinetochores become more prone to bind MTs coming from two poles due to the absence of the physical barrier normally created by the presence of another sister chromatid. Many other cellular, genetic and molecular causes of merotelic attachments have been hypothesized, of which the most significant ones are outlined below.
Causes of merotelic attachments: aberrant spindle morphology. One way in which merotelic attachments can arise is through abnormal spindle assembly in mitosis. Initial clues on this came from the observation that multipolar spindle assembly in kangaroo cells often led to kinetochore-binding to two spindle poles, 110 producing merotelic attachments and lagging chromosomes. 111 Thus, proper spindle polarity is important for the establishment of proper chromosome attachments. In mammalian cells, spindle polarity is largely dictated by the centrosomes. The two centrosomes that are normally present separate before mitosis, and subsequently organize the spindle poles. Drugs that perturb centrosome separation also increase the number of merotelic attachments and induce chromosome segregation errors. 107 Interestingly, multipolar spindles are often observed in CIN tumors, [112] [113] [114] [115] which indicates that aberrant spindle morphology might be responsible for merotelic attachments and CIN induction in vivo as well. Multipolar spindles are often the result of centrosome overduplication, a common trait of cancer cells. 116 Persistence of multipolar spindles in anaphase results in severe chromosome missegregations and the severely aneuploid daughter cells often die in the next G1 phase. 117 However, tumor cells that harbor multiple centrosomes can progress through a transient multipolar state, after which the supernumerary centrosomes cluster during mitosis and form a seemingly normal bipolar spindle 118, 119 ( Figure 3 ). The transient multipolar state that results from having too many centrosomes is very prone to attach single kinetochores to multiple spindle poles. 110, 111, 118, 119 These multipolar attachments are converted to merotelic attachments upon centrosome clustering and can produce chromosome segregation errors 118, 119 ( Figure 3 ). Supernumerary centrosomes can arise through a number of different mechanisms, such as centrosome overduplication, cytokinesis failure or virus-induced cell fusion, with the last two also resulting in increased ploidy. Interestingly, tetraploidy is also frequently observed in tumor cells and has been shown to promote tumorigenesis in mice 120 as well as transformation in vitro and in vivo. 121 It is currently unclear if the tumorigenic nature of a tetraploid cell is due to the fact that it contains an extra copy of the genome or because it contains twice the amount of centrosomes. The extra copy of the genome could set the stage for subsequent chromosome loss to produce the genetic imbalance that drives tumorigenesis. Alternatively, the extra centrosomes could be the critical driving force to produce that genetic imbalance by enhancing the chance of creating merotelic attachments.
Very recently, a novel and remarkable mechanism to produce tetraploid cells was described. The process was named 'entosis': the invasion of a cell into another cell. Entosis has been described as a non-apoptotic cell death program of cells that have been detached from the extracellular matrix. 122 Internalization of these detached cells into host cells most often results in cell death. Entosis has been observed in tumors, and its occurrence correlates with tumor grade. [122] [123] [124] Cells taken up by entosis are usually destroyed before the host divides, but if an intact invading cell ends up in the host cell's cleavage plane, it can inhibit cytokinesis. This produces a tetraploid cell that will build a multipolar spindle in the next mitosis, a combination that is likely to produce aneuploid daughter cells. 124, 125 This illustrates that one single cytokinesis failure could initiate chromosome segregation errors in the tumor cells' offspring, ultimately leading to CIN.
In addition to the abovementioned models for the induction of multiple centrosomes and subsequent aberrant spindle formation, loss of the DNA damage checkpoint kinase Chk2 has also been implicated in the induction of abnormal spindles through deregulation of MT dynamics. 126 Chk2 is thought to be important for proper spindle formation through phosphorylation of Brca1 on Serine 988. The fact that deregulated Chk2 functioning causes numerical CIN through abnormal spindle formation is intriguing, as the role of Chk2 in the maintenance of genetic stability has mainly been ascribed to its function in DNA damage checkpoint signaling. 127 Causes of merotelic attachments: increased stability of kinetochore microtubule attachments. The proper control of kinetochore-MT stability is another crucial factor that determines the fidelity of chromosome segregation (Figure 3) . Increasing the stability of MTs bound to kinetochores through depletion of MCAK or Kif2b, two kinetochore-localized MT depolymerases, results in increased occurrence of merotelic attachments and severe chromosome missegregations in human tumor cells. 128 A follow-up study in which kinetochore-MT turnover was compared between an untransformed cell line and several CIN lines, revealed that kinetochore MTs are more stable in the CIN lines. This increased kinetochore MT stability could impede error correction and result in misattachments that can persist until anaphase. 129 Importantly, increasing kinetochore-MT turnover in these CIN cell lines by overexpressing Kif2b or MCAK could partially revert the CIN phenotype. 129 More recently an unexpected link was reported between MAD2 overexpression, often found in CIN tumors, and increased kinetochore-MT stability. It was shown that MAD2 overexpression causes a reduction in Aurora B levels and activity at the centromeres, indicating that MAD2 overexpression inhibits error correction, providing a plausible explanation for the increased segregation errors seen in these cells. 130 The authors showed that the effect on Aurora B localization is independent of the checkpoint function of MAD2, but the exact mechanism responsible for the loss of Aurora B remains to be elucidated. The effect on Aurora B localization and activity is in line with another study, which suggested that the Aurora B-dependent error correction machinery works more efficiently in healthy cells when compared with that of tumor cells. 131 Since MAD2 overexpression results in chromosome segregation errors and tumorigenesis in mice, 90, 93 aberrant Aurora B localization and activation could very well explain the CIN observed in MAD2-overexpressing tumors.
One other interesting possibility that could explain the increased stability of kinetochore-MTs observed in CIN cells, 128 is inactivation of the tumor-suppressor gene adenomatous polyposis coli (APC), which is frequently mutated in colon carcinomas. 132 There is ample evidence that mutation of APC is an initiating event in colon tumorigenesis, and that the effect of APC inactivation on tumorigenesis is mediated through the Wnt pathway. 133 Nonetheless, APC also affects MT dynamics and APC loss and CIN are found to coincide in early cancer lesions. 134 Also, APC loss-of-function has been shown to directly result in genetic instability. 135, 136 This latter effect is thought to, at least partially, be dependent on the function of APC in kinetochore-MT stability. [137] [138] [139] APC localizes to centrosomes, kinetochores and MT plus-ends, 134 and depletion of APC results in reduced inter-kinetochore tension, which is thought to be due to decreased kinetochore-MT dynamics. 137, 138 Although a very interesting hypothesis, future research will have to assess if APC loss produces CIN through altered MT dynamics or through activation of Wnt signaling, as the activation of Wnt target genes could also result in the induction of CIN.
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Causes of merotelic attachments: multiple attachment sites. The presence of extra centromeres on chromosomes could be another cause of lagging chromosomes ( Figure 3 ). As discussed above, aberrantly structured chromosomes, such as ring chromosomes or fusion of multiple chromosomes have a high chance of ending up in the cleavage furrow during telophase. These chromosomes often have multiple centromeres and kinetochores, creating multiple MT attachment sites that complicate chromosome biorientation. The multiple kinetochores present on a single chromatid can attach to opposite poles, effectively creating 'merotelic' attachments [142] [143] [144] (Figure 3 ). Upon exit from mitosis, Figure 3 . Schematic representation of underlying causes of merotelic attachments. Centrosome coalescence creates merotelic attachments by allowing clustering of centrosomes, which had already established MT interactions with kinetochores. Impaired kinetochore MT dynamics inhibits the release of erroneous attachments, whereas the presence of multiple centromeres increases the chance of creating faulty attachments.
Genetic instability in tumors A Janssen and RH Medema this bipolarly attached chromatid would lag behind, causing whole-chromosome gain or loss, 20, 24, 142, 144 or initiate a BFB cycle as discussed above. These data indicate that structural chromosomal aberrations and numerical CIN are closely linked and show that DNA damage due to, for example, replication defects, 145, 146 telomere defects 24, 102, 144, 147 or DNA-repair defects 148 could, besides structural CIN, eventually result in numerical CIN as well.
Another cause of multiple centromere formation could be the random incorporation of CENP-A at heterochromatic sites, other than the core centromeric region. CENP-A is a Histone H3-like protein, which specifically integrates at centromeric nucleosomes and is required for the proper formation of centromeres and kinetochores. 149 It has been shown in Drosophila (cells) that overexpression of CENP-A can directly result in the localization of CENP-A into noncentromeric regions. 142 This leads to ectopic kinetochore formation, resulting in an increase in erroneous MT attachments upon mitotic entry and ultimately severe chromosome segregation errors. Enhanced levels of CENP-A and its targeting factor HJURP have been found in both breast and colon cancer. 150, 151 However, in human cells, contradictory data have been obtained on the effects of ectopic localization of CENP-A. It has been suggested that CENP-A presence is not sufficient to drive complete de novo kinetochore formation, 152 whereas other studies have shown it can. 153 Thus, it is unclear if mere overexpression of CENP-A is sufficient for the induction of CIN through creation of multiple attachment sites.
NUMERICAL CIN AND DNA DAMAGE
Both structural and numerical chromosomal changes arise in the majority of cancer cells. 6, 8 As described above, it has been known for several decades that structural chromosomal aberrations can induce chromosome segregation errors upon cell division. 20 However, it has only recently been revealed that the opposite also occurs: chromosome segregation errors can induce structural chromosomal changes through generation of DSBs. [154] [155] [156] Duesberg et al. 157, 158 initially observed that the severity of aneuploidy coincides with an increase in structural chromosomal changes, and several CIN model systems displayed structural chromosomal aberrations as well. 8, 33, 93, 120, 159 However, the underlying mechanisms for this correlation remained unknown. By generating 13 aneuploid yeast strains that each harbor an extra single chromosome in addition to the haploid content, it was recently shown that aneuploidy can directly induce genomic instability 156 ( Figure 4 ). Aneuploidy of a single chromosome in some cases resulted in chromosome missegregations, whereas in others, the abnormal chromosome number induced a high mutation rate. This increased genomic instability is thought to be due to both an increase in DSBs and defects in recombinational repair. 156 The underlying cause of the increase in DSBs remains largely unknown, but could be due to aneuploidy-induced imbalances in protein stoichiometry. 160, 161 Indeed, diploid yeast strains carrying a single extra chromosome did not display an increase in genomic instability. 156 In addition to defects induced by aneuploidy per se, it was also recently shown that single chromosome missegregation events, the underlying cause of aneuploidy induction, can also directly lead to DNA damage 154, 155 ( Figure 4) .
Micronuclei, small nuclear compartments that are surrounded by a nuclear envelope, in general, contain one or two chromosomes that missegregated in the preceding mitosis. 12, 24 These micronuclei undergo replication defects in the next S and G2 phase, due to incomplete recruitment of DNA replication factors, such as the DNA helicase components MCM2 and MCM3 and the initiation factor Cdt1. 154 These replication defects result in persistent DNA damage in micronuclei, providing a link between chromosome segregation errors and genomic instability (Figure 4 ).
Besides DNA damaging events that occur in the S phase following an aberrant mitosis, it has also been shown that lagging chromosomes can be damaged during telophase. 155 Following both artificially induced chromosome segregation errors and spontaneous missegregations in CIN cancer cells, chromatin was found to be damaged in telophase and the next G1 phase. 155 The occurrence of these DSBs could be (partially) rescued by inhibiting cytokinesis, suggesting that cleavage furrow ingression causes damage to the lagging chromosomes (Figure 4) .
How ingression of the furrow could impose sufficient force to damage the lagging chromatin is unclear. It could be that the mechanical force exerted through contraction of the actin-myosin ring can break the lagging chromatid. In this respect it will be interesting to see whether the furrow is actually in direct contact with the lagging chromatin and whether this physical contact coincides with the observed DNA damage.
An interesting hypothesis is that fragile sites present on lagging chromosomes could render them more prone to breakage when present in the cleavage furrow. It has been shown that fragile sites induced by replication defects are protected from further destabilization and breaking in G1 through the recruitment of 53BP1. 162, 163 Hypothetically, cleavage furrow ingression in the presence of these underreplicated hotspots could promote breakage of lagging chromosomes before 53BP1 has accumulated to protect these loci. Another cause of missegregation-induced DNA damage could be the presence of an increased, centromere-localized force imposed by MTs coming from the two spindle poles. This has also been suggested by an earlier study, in which the authors observed centromere-localized DNA damage foci in interphase CIN cells. 164 To address this point, future studies should determine whether inhibition of this centromere-localized force can reduce the damage.
Nevertheless, these recent findings [154] [155] [156] reveal new mechanisms by which CIN and aneuploidy promote genomic instability in cancer cells (Figure 4 ). The reciprocal relationship between numerical and structural chromosomal changes complicates analysis of the direct effects of either structural chromosomal changes or numerical CIN on tumor formation and reveals additional ways in which heterogeneity arises in tumors.
CHROMOSOME SEGREGATION ERRORS AND TUMORIGENESIS
Boveri 165 was the first to postulate that chromosomal aberrations could be a causal factor in the occurrence of cancer after von Hansemann had observed the presence of chromosomal abnormalities and mitotic errors in cancer cells. 166 At present, the impact of structural changes on cancer progression is quite well understood, 2 whereas the effects of numerical changes on tumorigenesis remain highly debated. 46, 167 Numerical chromosomal instability has been observed in early neoplastic lesions 168 and is thought to be able to cause transformation. [169] [170] [171] In addition, aneuploidy, one of the common consequences of CIN, can drive evolution by introducing phenotypic variation in several budding yeast strains. 172, 173 In line with a role for CIN in tumorigenesis, CIN has been associated with poor prognosis and resistance to chemotherapeutics in human patients. [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] Below, we summarize some of the main findings on the consequences of CIN on tumor cells and tumor formation. For a more comprehensive summary of the most recent advances in our understanding of the consequences of CIN, we refer to a set of recently published reviews, which specifically summarize this aspect of CIN. 46, 174, 175 Several CIN mouse models have been generated with deletions or hypomorphic alleles of genes important for mitotic fidelity (Table 1) . Homozygous deletion of genes required for faithful mitotic progression leads to embryonic lethality. 53, 57, 58, 79, 171, [176] [177] [178] [179] Haploinsufficiency of mitotic genes, however, is tolerated in all cases and is therefore used extensively to investigate in the effects of CIN in tumorigenesis. Following recent findings that mitotic Genetic instability in tumors A Janssen and RH Medema genes are more frequently upregulated than downregulated in CIN tumors, various mouse models have been generated that overexpress genes involved in mitotic progression, such as the mitotic checkpoint genes Bub1 180 and MAD2 93 and the E2 enzyme UbcH10 181 (Table 1) . Below we discuss the insights that these various models have generated with respect to the contribution of CIN in tumor formation.
Tumor-promoting role of numerical CIN Haploinsufficiency, hypomorphy or overexpression of genes involved in mitotic progression can result in CIN. Although aneuploidy levels vary between different mouse models, 167 CIN generally seems to be able to enhance tumorigenesis. Treatment with carcinogens, such as DMBA, leads to increased tumor incidence in 6 out of 10 CIN models tested (see Table 1 ) and crossing some of the CIN models with tumor-prone mouse models, such as Em-myc 93, 180 or APC min/ þ 182,183 mice, results in enhanced or accelerated tumor formation (Table 1) . Many CIN mouse models also display an increased susceptibility to spontaneous tumor formation in lung, liver and lymph nodes, albeit at a relatively old age (Table 1) 178 but BubR1 H/H animals do not display an increased tumor incidence, whereas Bub1 hypomorphic animals do. These discrepancies could be due to additional roles of these checkpoint proteins in other cellular processes. Indeed, BubR1 hypomorphic animals also develop severe ageing-associated phenotypes, indicating that BubR1 has additive functions in maintaining cell homeostasis, possibly through regulation of p16 and p19 protein levels. 57, 184 One striking similarity in the spectrum of spontaneously developing tumors in the various CIN models is the formation of lung tumors. This resemblance indicates that, for unknown reasons, CIN specifically enhances tumorigenesis in lung epithelial cells.
One single chromosome missegregation event results in the loss or gain of one complete chromosome and thereby affects a large number of genes. The fact that CIN tumor cells continuously change their chromosome composition indicates that CIN causes extensive phenotypic changes, as signified by the increased overall transcriptomic and proteomic activity in aneuploid yeast strains. 160 These dramatic changes in genetic make-up make it difficult to determine how CIN could be exactly contributing to tumorigenesis. One, rather simple, hypothesis is that CIN is able to promote tumorigenesis by inducing loss of certain tumor-suppressor genes or gain of oncogenes. In line with this, crossing a CIN mouse model carrying a hypomorphic Bub1 allele with tumor-prone mouse models heterozygous for p53 or APC min resulted in loss of heterozygosity of these tumor-suppressor genes and enhanced tumor formation. 182 CIN could indeed be quite effective in inducing loss of heterozygosity, as it will immediately induce loss of multiple genes.
However, since aneuploidy can lead to loss or gain of multiple essential genes, it is very likely to be detrimental to cells. 52, 54, 160, 161 It is therefore thought that coinciding mutations would have to arise in other pathways to render the cell insensitive to changes in chromosome number. 46 Examples of such changes are loss of function of p53 185 or mutations that promote proteasomal degradation in order to circumvent the increases in protein production obtained by gain of chromosomes. 186 These mutations in turn could allow the induction of other transforming changes, which ultimately lead to tumorigenesis. Alternatively, CIN and aneuploidy could promote tumorigenesis through the creation of a mutator phenotype in cells. 42, 187 Aneuploidy could affect levels of DNA repair genes, and thereby promote genomic instability. In line with this hypothesis, aneuploidy was initially found to correlate with genomic instability in cancer cells 158 and has recently been shown to induce genomic instability in budding yeast. 156 Moreover, CIN could itself be a mutator by inducing DNA damage and structural chromosomal changes through micronuclei formation 154 or cleavage furrow ingression in the presence of lagging chromosomes. 155 Interestingly, crossing a CIN mouse model with a mouse model deficient for ATM resulted in accelerated tumor formation, 188 consistent with the notion that CIN-induced tumor formation involves the induction of DNA damage.
In summary, CIN and aneuploidy could together create a state in which cancer cells not only continuously lose and gain whole 
Genetic instability in tumors A Janssen and RH Medema chromosomes, but also acquire new mutations and translocations, which interfere with the function of genes involved in DNA repair, mitotic fidelity and cell cycle progression, thereby promoting transformation and drug resistance.
Tumor-suppressive role of numerical CIN Although CIN correlates in most models with increased tumor formation, several cases of CIN-associated tumor suppression have also been described (Table 1 ). In particular, animals heterozygous for the motor protein CENP-E showed a significant decrease in spontaneous liver tumor formation, decreased tumor incidence in a p19 heterozygous background and a clear reduction in carcinogen-induced tumor formation. 171 Similarly, BubR1 heterozygosity decreased intestinal tumor incidence in the tumor-prone APC min/ þ model 183, 189 and Bub1 hypomorphy reduced the number of prostate lesions when crossed with heterozygous PTEN animals. 182 In line with this, inverse correlations between CIN and patient prognosis in various tumor types have also been described. 190, 191 This suggests that an optimal level of CIN exists, which, dependent on the tissue, results in either tumorigenesis or tumor suppression. Excessive CIN could compromise genome stability in such a way that it is incompatible with cell viability. Mild CIN could promote growth by providing the tumor cell with a level of genetic instability that is moderate enough to maintain a relatively stable genome, while at the same time providing enough genetic variation in the population to allow for rapid adaptation to changes in the tumor environment. If a maximal tolerated level of CIN does exist for tumors, this feature could be exploited in future anticancer strategies. 192 This paradoxical relationship between CIN, tumorigenesis and cell viability is a highly debated topic and future research will hopefully lead to more insight on the role of CIN in tumorigenesis, but also allow for the successful development of new anticancer strategies specifically targeting CIN or aneuploid tumor cells.
CONCLUDING REMARKS
The question remains whether CIN is an initiator of tumorigenesis, whether it mainly provides an enhancing effect to promote transformation or if it is a mere consequence of tumor formation. The fact that CIN is a common trait of 470% of all tumors makes it unlikely to simply be a bystander to tumorigenesis. Whole genome sequencing of early neoplasia in either mouse models or human patients in combination with assessment of CIN status could provide more insight on the role of CIN in human tumor formation. Generation of CIN mouse models in which CIN can be induced during later stages of development, will hopefully also provide more knowledge on the effect of CIN in tumorigenesis and tumor suppression. In most of the current CIN mouse models, CIN is induced already during embryonic development, which makes it difficult to draw conclusions about tumor development in the adult life. In addition, improving diagnostic tools to visualize CIN in tissues of mouse models, but also human patients, should help in evaluating the various levels of CIN and the impact thereof on tumorigenesis. 174 These tools should help to solve the discrepancies currently found between different mouse models of CIN and improve our understanding of the role of CIN in human tumorigenesis.
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